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(57) ABSTRACT 
A method of determining the presence of pulmonary embo-
lism is a postoperative patient using the carbox ratio of the 
patient prior to the surgical procedure and the carbox ratio of 
the patient after to the surgical procedure. The characteristics 
of the breath of the patient are obtained prior to a surgical 
procedure for a baseline and then afterwards if the patient has 
difficult breathing. The mean carbox ratios from the baseline 
and post-surgical data collections are then compared to non-
invasively predict the likelihood that the patient has devel-
oped pulmonary embolism. A decrease in the carbox ratio of 
more than twenty-five percent (25%) represents an abnormal 
test and is consistent with possible pulmonary embolism. No 
change or an increase in the carbox ratio suggests the absence 
of pulmonary embolism. 
20 Claims, 5 Drawing Sheets 
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METHOD AND SYSTEM FOR DIAGNOSING 
POST-SURGICAL PULMONARY VASCULAR 
OCCLUSIONS 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This application is a continuation-in-part of U.S. patent 
application Ser. No. 11/160,960, filed on Jul. 18, 2005, which 
is a divisional of U.S. patent application Ser. No. 10/400,339, 
filed on Mar. 26, 2003, which is a divisional of U.S. patent 
application Ser. No. 09/965,303, filed on Jun. 10, 2003. 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH OR DEVELOPMENT 
The U.S. Government has a paid-up license in this inven-
tion and the right in limited circumstances to require the 
patent owner to license others on reasonable terms as pro-
vided for by the terms of Grant No. R42 HL086316-01 
awarded by the National Institutes of Health. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The present invention relates to vascular occlusions of the 
respiratory system, and more particularly to a non-invasive 
method for the diagnosis of pulmonary embolism and related 
disorders. 
2. Description of the Related Art 
2 
ments, there is no individual finding or combination of find-
ings from the arterial blood gas analysis that allows either a 
reliable way to exclude or specific way of diagnosing pulmo-
nary embolism. In particular, at least 15-20% of patients with 
a documented pulmonary embolism have normal oxygen and 
carbon dioxide contents of the arterial blood. Accordingly, 
the arterial blood analysis cannot reliably include or exclude 
the diagnosis of a pulmonary embolism. 
The blood D-dimer assay is another diagnostic method that 
10 has become available for commercial use. The D-dimer pro-
tein fragment is formed when fibrin is cleaved by plasmin and 
therefore produced naturally whenever clots form in the body. 
As a result, the D-dimer assay is extremely sensitive for the 
presence of a pulmonary embolism but is very nonspecific. In 
15 other words, if the D-dimer assay is normal, the clinician has 
a reasonably high degree of certainty that no pulmonary 
embolism is present. However, many studies have shown a 
D-dimer assay is only normal in less than 1/3 of patients and 
thus produces a high degree of false positives. As a result, the 
20 D-dimer assay does not obviate formal pulmonary vascular 
imaging in most patients with symptoms of a pulmonary 
embolism. 
In an attempt to increase the accuracy of diagnostic, phy-
sicians have recently turned to methods which can produce an 
25 image of a potentially afflicted lung. One such method is a 
nuclear perfusion study which involves the injection of a 
small amount of radioactive particles into a vein. The radio-
active particles then travel to the lungs where they highlight 
the perfusion of blood in the lung based upon whether they 
30 can penetrate a given area of the lung. While normal results 
can indicate that a patient lacks a pulmonary embolism, an 
abnormal scan does not necessarily mean that a pulmonary 
embolism is present. Nuclear perfusion is often performed in 
A pulmonary embolism occurs when an embolus becomes 
lodged in lung arteries, thus blocking blood flow to lung 
tissue. An embolus is usually a blood clot, known as a throm-
bus, but may also comprise fat, amniotic fluid, bone marrow, 
tumor fragments, or even air bubbles that block a blood ves- 35 
sel. Unless treated promptly, a pulmonary embolism can be 
fatal. In the United States alone, around 600,000 cases occur 
annually, 10 percent of which result in death. 
conjunction with a lung ventilation scan to optimize results. 
During a lung ventilation scan, the patient inhales a gas-
eous radioactive material. The radioactive material becomes 
distributed throughout the lung's small air sacs, known as 
alveoli, and can be imaged. By comparing this scan to the 
blood supply depicted in the perfusion scan, a physician may The detection of a pulmonary embolism is extremely dif-
ficult because signs and symptoms can easily be attributed to 
other conditions and symptoms may vary depending on the 
severity of the occurrence. Frequently, a pulmonary embo-
lism is confused with a heart attack, pneumonia, hyperventi-
lation, congestive heart failure or a panic attack. In other 
cases, there may be no symptoms at all. 
Often, a physician must first eliminate the possibility of 
other lung diseases before determining that the symptoms, if 
any, are caused by a pulmonary embolism. Traditional diag-
nostic methods of testing involve blood tests, chest X-rays, 
and electrocardiograms. These methods are typically more 
effective in ruling out other possible reasons than for actually 
diagnosing a pulmonary embolism. For example, a chest 
x-ray may reveal subtle changes in the blood vessel patterns 
after an embolism and signs of pulmonary infarction. How-
ever, chest x-rays often show normal lungs even when an 
embolism is present, and even when the x-rays show abnor-
malities they rarely confirm a pulmonary embolism. Simi-
larly, an electrocardiogram may show abnormalities, but it is 
only useful in establishing the possibility of a pulmonary 
embolism. 
As a pulmonary embolism alters the ability of the lungs to 
oxygenate the blood and to remove carbon dioxide from the 
blood, one method of diagnosing the condition involves tak-
ing a specimen of arterial blood and measuring the partial 
pressure of oxygen and carbon dioxide in the arterial blood 
(i.e., an arterial blood gas analysis). Although a pulmonary 
embolism usually causes abnormalities in these measure-
40 be able to determine whether the person has a pulmonary 
embolism based upon areas that show normal ventilation but 
lack sufficient perfusion. Nevertheless, a perfusion scan does 
not always provide clear evidence that a pulmonary embolism 
is the cause of the problem as it often yields indeterminate 
45 results in as many as 70% of patients. 
Pulmonary angiograms are popular means of diagnosing a 
pulmonary embolism, but the procedure poses some risks and 
is more uncomfortable than other tests. During a pulmonary 
angiogram, a catheter is threaded into the pulmonary artery so 
50 that iodine dye can be injected into the bloodstream. The dye 
flows into the regions of the lung and is imaged using x-ray 
technology, which would indicate a pulmonary embolism as 
a blockage of flow in an artery. Pulmonary angiograms are 
more useful in diagnosing a pulmonary embolism than some 
55 of the other traditional methods, but often present health risks 
and can be expensive. Although frequently recommended by 
experts, few physicians and patients are willing to undergo 
such an invasive procedure. 
Spiral volumetric computed tomography is another diag-
60 nostic tool that has recently been proposed as a less invasive 
test which can deliver more accurate results. The procedure's 
reported sensitivity has varied widely, however, and it may 
only be useful for diagnosing an embolism in central pulmo-
nary arteries as it is relatively insensitive to clots in more 
65 remote regions of the lungs. 
These pulmonary vascular imaging tests have several dis-
advantages in common. Nearly all require ionizing radiation 
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and invasiveness of, at a minimum, an intravenous catheter. 
The imaging tests also typically involve costs of more than 
$1,000 for the patient, take more than two hours to perform, 
and require special expertise such as a trained technician to 
perform the tests and acquire the images and a board-certified 
radiologist to interpret the images. Notably, none are com-
pletely safe for patients who are pregnant. As a result of these 
shortcomings, the imaging procedures are not available in 
many outpatient clinic settings and in many portions of third 
world countries. 
With respect to postoperative care, the disadvantages of CT 10 
4 
FIG. 1 is an illustration of a respiratory system during 
inhalation. 
FIG. 2 is an illustration of a respiratory system during 
exhalation. 
FIG. 3 is an illustration of a respiratory system afflicted 
with a pulmonary vascular occlusion during exhalation. 
FIG. 4 is a schematic representation of the system of the 
present invention. 
FIG. 5 is a perspective view of an attachment to the inven-
tion. 
angiography include need for patient transport, 60-180 min to 
perform and interpret the scan, need for special equipment 
and technician availability, need for radiologist availability to 
interpret, significant renal toxicity from contrast, risk of 
allergy, significant dose of radiation and increased lifetime 15 
risk of death from cancer, and $2000 charge. The ventilation-
perfusion lung scan suffers from limited availability, time to 
perform, need for special expertise to perform and interpret, 
and a very low rate of findings that definitively exclude or 
diagnose pulmonary embolism in the post-surgical popula- 20 
ti on. The blood test known as the D-dimer can also be used to 
rule out pulmonary embolism in ambulatory patients, but 
surgery causes the D-dimer to increase in a very unpredict-
able way. Hence, the D-dimer suffers from very low diagnos-
FIG. 6 is an illustration of a display screen readout. 
FIG. 7 is a flowchart of a method of non-invasively indi-
cating the presence of pulmonary embolism in a post-opera-
tive patient. 
FIGS. SA and B are scatter plots showing the accuracy of 
the present invention as compared to a convention method of 
determining the presence of pulmonary embolism. 
DETAILED DESCRIPTION OF THE INVENTION 
Referring now to the drawing in which like reference 
numerals refer to like parts throughout, there is seen in FIG. 1 
a representation oflungs 10 free from any pulmonary occlu-
sions. In healthy lungs 10, blood flows freely from the pul-
tic specificity in the post-surgical population. 
BRIEF SUMMARY OF THE INVENTION 
It is therefore a principal object and advantage of the 
present invention to provide a method for non-invasively 
diagnosing postoperative pulmonary vascular occlusions that 
does not require specialized technicians. 
It is an additional object and advantage of the present 
invention to provide a method for non-invasively diagnosing 
postoperative pulmonary vascular occlusions that is not 
expensive. 
It is a further object and advantage of the present invention 
to provide a method for non-invasively diagnosing postop-
erative pulmonary vascular occlusions that is easy to use. 
It is another object and advantage of the present invention 
25 monary arteries 12 into the capillaries 14 surrounding the 
individual alveoli 16 of the lungs 10. When inhaled air 18 is 
drawn into the lungs 10 and alveoli 16, oxygen is transferred 
from the inhaled air 18 to the blood stream and carbon dioxide 
is transferred out. Inhaled air 18 typically contains an oxygen 
30 partial pressure of approximately one hundred (100) torr and 
a carbon dioxide partial pressure of zero (0) torr. 
Once the inhaled air 18 reaches the alveoli 16, the oxygen 
content decreases while the carbon dioxide content increases 
until an equilibrium with blood gas levels in the pulmonary 
35 arteries 12 is reached. The inhaled air 18 is then, as seen in 
FIG. 2, expired as exhaled air 20. Exhaled air 20 from prop-
erly functioning lungs typically contains a partial pressure of 
oxygen of about eighty (80) torr and a partial pressure of 
carbon dioxide of about forty ( 40) torr. 
to provide a method for non-invasively diagnosing postop- 40 
erative pulmonary vascular occlusions that is accurate. 
FIG. 3 depicts the functioning of a respiratory system 
afflicted with a pulmonary embolism 22 which, as an 
example, occludes blood flow to an afflicted lung 24. As a 
result, there is a reduction in the number of alveoli 16 that 
participate in gas exchange. This volume of space available in 
In accordance with the foregoing objects and advantages, 
the present invention comprises a method of determining the 
presence of pulmonary embolism is a postoperative patient. 
The first step is the preoperative collection of data obtained 
from the breath of the patient. The patient is allowed to 
breathe the ambient air for two minutes, and is then seated in 
a semi-Fowler's position and given with comfortable nose 
clips. The patient is next provided with and asked to breath 
through the device of the present invention. The data obtained 
by the device is qualified against predetermined criteria and, 
if acceptable, stored in memory. After an operation, the col-
lection process is repeated ifthe patient experiences difficulty 
breathing. The mean carbox ratios from the baseline and 
post-surgical data collections are then compared to non-inva-
sively predict the likelihood that the patient has developed 
pulmonary embolism. For example, a decrease in the carbox 
ratio of more than twenty-five percent (25%) represents an 
abnormal test and is consistent with possible pulmonary 
embolism. No change or an increase in the carbox ratio sug-
gests the absence of pulmonary embolism. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The present invention will be more fully understood and 
appreciated by reading the following Detailed Description in 
conjunction with the accompanying drawings, in which: 
45 the alveoli 16 that is lost from participation is commonly 
referred to as alveolar deadspace. Due to the deadspace and 
loss of total alveolar volume available for gas exchange, 
afflicted lung 24 does not exchange gases as readily as the 
healthy lung 10. Accordingly, exhaled air 26 contains a higher 
50 partial pressure of oxygen and lower partial pressure of car-
bon dioxide than air exhaled from a healthy lung. In the 
example depicted in FIG. 3, exhaled air 26 exiting the respi-
ratory system contains a partial pressure of oxygen of about 
eighty-five (85) torr and a partial pressure of carbon dioxide 
55 of about twenty (20) torr. Thus, the ratio of carbon dioxide to 
oxygen in exhaled air 26 from afflicted lung 24 (i.e., 20:85) is 
smaller than the ratio in exhaled air 20 from healthy lung 10 
(i.e., 40:80) as seen in FIG. 2. 
As seen in FIG. 4, a system 28 for measuring and diagnos-
60 ing pulmonary disorders comprises a measuring unit 30 in 
combination with a data processing unit 50 and a display 
screen 60. Measuring unit 30 determines the overall flow of 
air inhaled into and exhaled out of the lungs while simulta-
neously determining the partial pressure of oxygen and car-
65 bon dioxide. Data processing unit 50 computes the concen-
trations of carbon dioxide, oxygen, and nitrogen from the 
partial pressures and determines the ratio of carbon dioxide to 
US 7,998,084 B2 
5 
oxygen from the raw data obtained by measuring unit 3 0. The 
ratio of carbon dioxide to oxygen is then plotted against 
expired volume on display screen 60. By comparing the car-
bon dioxide ratios to average readings, the likelihood that a 
given patient has a pulmonary embolism can be determined. 
Measuring unit 30 comprises a patient mouthpiece 32 con-
nected in fluid communication to a breathing tube 34 having 
6 
curves over a predetermined time period. For the purposes of 
determining cardiac output, a one minute time period is suf-
ficient. The arterial oxygen content can be estimated by mul-
tiplying the arterial oxygen saturation (measured by pulse 
oximeter 44) by the hemoglobin concentration (determined 
from the venous blood sample). The venous oxygen content 
can be calculated by mathematical manipulation of the nadir 
(mean lowest) oxygen tension measured during deep expira-
tion (in an awake patient) or a sign exhalation (in a mechani-
cally ventilated patient) over the predetermined time period. 
From the nadir oxygen tension, venous oxygen saturation can 
be estimated according to published oxygen binding curves 
for the measured pH. The venous oxygen content is then 
calculated by multiplying the venous oxygen saturation by 
the venous hemoglobin (measured from the venous blood 
sample). Once these calculations have been made, the cardiac 
output is determined by dividing the total oxygen consumed 
by the difference between the arterial oxygen content and the 
venous oxygen content. The algorithm for the Fick calcula-
an open end 42 through which air can be inhaled or exhaled. 
Measuring unit 30 further comprises three sensors; a pneu-
motach 36, a capnometer 38, and an oxygen monitor 40. The 10 
three sensors are situated in series and in-line with breathing 
tube 34 for simultaneously measuring the flow, carbon diox-
ide, and oxygen levels of inhaled and exhaled air. Infrared and 
paramagnetic type sensors are preferred respectively. Sensors 
using spectrometric techniques may also work for both oxy- 15 
gen and carbon dioxide measurements providing they can 
supply data with rapid enough response time for breath-to-
breath, real-time plotting. The mainstream technique for 
measuring the inhaled or exhaled air is preferred, but the 
sidestream technique may also be effective. 
As seen in FIG. 5, a T-piece adaptor 70 may optionally be 
provided at open end 42 of breathing tube 34 for use with 
patients that are oxygen dependant. T-piece adapter 70 con-
tains an inlet valve 72 and an outlet valve 74 which properly 
direct the passage of inhaled and exhaled air through the 25 
breathing tube 34. By connecting an oxygen dependant 
patient's supply to the intake valve 72, inhaled air can first be 
passed through the three sensors 36, 38, 40 to establish base-
line readings of the oxygen and carbon dioxide concentra-
tions for comparison to exhaled air, since an oxygen depen- 30 
dent patient receives air that has different concentrations than 
present in ambient air. 
20 tion can be progranimed into the data processing unit soft-
ware and the results displayed on screen 60. The cardiac 
output measurement is useful for assisting the physician in 
determining the success or failure of treatment designed to 
Data processing unit 50 comprises a commercially avail-
able computer processor progranimed with software for the 
interpretation of the data obtained from measuring unit 30 35 
and background comparison data. Software can be specifi-
cally developed to perform the necessary calculations to 
determine the partial pressures and carbon dioxide to oxygen 
ratios or software can optionally be purchased commercially 
and, if necessary, modified to run the appropriate algorithms. 40 
After additional research, the background comparison data 
can be updated based on data obtained from use of the inven-
tion to further refine expected normal values. 
Display screen 60 comprises a cathode ray tube, plasma 
screen, or other visual display for displaying computerized 45 
data. Screen 60 can optionally display graphs representing 
predetermined reference or background data for test popula-
tions against which the current readings can be plotted for a 
visual comparison. In addition to displaying the carbon diox-
ide to oxygen ratios as a function of time calculated by data 50 
processing unit 50, screen 60 may optionally display a plot of 
the expired oxygen and carbon dioxide partial pressures. 
Using this display, a physician may estimate the efficiency of 
alveolar ventilation in patients with acute respiratory distress 
syndromes to assist in deciding the mechanical ventilation 55 
settings. 
In addition to the three primary sensors 36, 38, 40, data 
processing unit 50 may optionally be connected to a pulse 
oximeter 44 that measures arterial oxygen saturation of 
hemoglobin in the arterial blood. From these data, and the 60 
additional measurement of pH and hemoglobin concentration 
in a peripheral venous blood sample, the cardiac output of the 
patient can be calculated according to the Fick equation. In 
order to perform the Fick equation, the average total oxygen 
consumed, the arterial oxygen content and venous oxygen 65 
content must be determined. The average total oxygen con-
sumed can be determined from the oxygen tension and flow 
relieve pulmonary vascular obstructions, or to treat circula-
tory shock. 
Device 28 is used by having a patient breathe (inhale and 
exhale a predetermined number of times in succession) 
through mouthpiece 32 of the measuring unit 30. As the 
patient inhales and exhales the pneumotach flow sensor 36, 
capnometer 38, and oxygen monitor 40 perform their respec-
tive readings, which are then electrically transmitted via 
wires or cabling to data processing unit 50. The program-
mable software loaded into data processing unit 50 convert 
the measurements into volume and concentration readings, 
calculate the carbon dioxide to oxygen ratio, and display this 
ratio on screen 60 in the form of a graph against the volume of 
air expired. Readings may be optimized by requiring the 
patient to hold in inhaled air for several heartbeats before 
exhaling through the mouthpiece 32 of the measuring unit 30. 
It has been determined through testing that patients without a 
pulmonary embolism will normally have a carbon dioxide to 
oxygen ratio of0.30 or greater while patients with a pulmo-
nary embolism will have a carbon dioxide to oxygen ratio of 
0.25 or less. 
Device 28 may also be used for the detection of whole-
body oxygen consumption and determination of the adequacy 
of oxygen delivery during resuscitation from shock. During 
conditions of systemic inflammation the body will extract 
oxygen at higher levels than normal, resulting in an increase 
in the partial pressure of carbon dioxide-to-oxygen ratio in 
exhaled air. By using T-piece 70 in the manner explained 
above, the concentration of the oxygen provided to the patient 
and the concentration of the oxygen exhaled can be deter-
mined. As illustrated in FIG. 6, when the level of oxygen 
delivery (i.e., the amount provided minus the amount 
exhaled) observed at two inspired oxygen concentrations 
reaches normal levels a physician has visual conformation 
that the resuscitation performed is adequate. One method of 
determining the adequacy of resuscitation is to determine 
oxygen delivery at both relatively low fixed concentrations of 
oxygen and at relatively high fixed concentration. Relatively 
low concentrations include from about twenty-one to thirty 
percent (21-30%) oxygen and relatively high oxygen concen-
trations involve about forty-five to one hundred percent (45-
100%) oxygen. The difference between oxygen delivery at 
relatively low concentrations verses relatively high concen-
trations can be compared against a nomogram for healthy 
US 7,998,084 B2 
7 
patients of similar age, body mass, body mass index, and 
gender and used to assess the adequacy of fluid and vasopres-
sor resuscitation. 
8 
able tidal volume as predicted from nomograms for height, 
age, gender, and race. When an adequate number of breaths 
that meet the criteria are obtained, the nose clips removed and 
data collection 82 is complete. From the data collected, the 
mean carbox ratio prior to a surgical procedure may be cal-
culated 84. The data obtained during this stage, including the 
carbox ratio, may be stored in a nonvolatile memory for 
comparison to subsequently obtained data. 
After a surgical procedure 86, a check is performed 88 to 
10 see whether the patient is having any difficult breathing. If 
not, the usual management of the patient is performed. If so, 
the data collection stage describe above is repeated to mea-
sure the characteristics of the breath of the patient after the 
surgical procedure 92. Data processing unit 50 then calculates 
Data processing unit 50 can additionally be programmed to 
display on screen 60 any of the individual measurements 
taken by sensors 36, 38, 40, and 44, or combinations thereof 
for diagnostic purposes. For example, a plot of the expired 
carbon dioxide and oxygen concentration over time could be 
used to estimate the efficiency of alveolar ventilation in 
patients with acute respiratory distress syndrome. Addition-
ally, the plotted data from sensors 36, 38, 40, and 44 could be 
used to assist in deciding how to properly adjust mechanical 
ventilators setting, such as the degree of positive end-expira-
tory pressure, minute ventilation, and peak inspiratory pres-
sure settings, to optimize patient care. For example, data from 
sensors 36, 37, 40, and 44, can be plotted individually in 
patients who are being mechanically ventilated. By simulta-
neously plotting the partial pressures of oxygen and carbon 
dioxide as a function of volume of each breath, the amount of 
carbon dioxide released and percentage of oxygen extracted 20 
can be determined. If the barometric pressure is known or 
inputted into data processing unit 50, the efficiency of alveo-
15 the mean carbox ratio after the procedure 94, and compares it 
to the mean baseline carbox ratio 96 from baseline collection 
82 and calculation 84. 
lar ventilation during each tidal volume breath can be calcu-
lated. This information can then be used to adjust mechanical 
ventilation to optimize alveolar efficiency or breathing alveo- 25 
lar ventilation efficiency. 
The device of the present invention allows for testing at the 
bedside and can be used to monitor for pulmonary embolism 
perioperatively. The device of the present invention may be 
used to take a baseline set of breath measurements of a patient 30 
at moderate- to high-risk for pulmonary embolism, the data 
may be stored, and then the baseline may for comparison to 
patient data obtained in the post operative phase. It will be 
obvious to anyone skilled in the art that this method can be 
used to monitor patients exposed to other recognized risks of 35 
pulmonary embolism, including deep venous thrombosis, 
heart failure, pregnancy, cancer, skeletal fractures, immobil-
ity, paralysis, drug therapy. 
Referring to FIG. 7, the first step in the intraoperative 
process 80 is to take baseline measurements 82 during pre- 40 
operative screening. Prior to obtaining the data, data process-
ing unit 50 should be provided with patient anthropomorphic, 
identifying and demographic data. The data may be inputted 
manually, or retrieved from a patient electronic records data-
base. The requisite measurements to be taken for the baseline 45 
include the tidal volume, respiratory rate, minute ventilation, 
peak inspiratory and expiratory flows, airstream temperature, 
expired partial pressures of C02 and 0 2 , and an automated 
secondary computation of the estimated airway deadspace 
using the method of Fletcher. The key respiratory-derived 50 
variable of interest is the "carbox ratio," which is the instan-
taneous ratio of expired partial pressure of carbon dioxide 
(pC02) divided by the partial pressure of oxygen (p02) at or 
near the end of a tidal volume breath. As explained above, the 
device of the present invention also records flow and volume, 55 
and allows computation of many variables derived from these 
measurements. 
During the collection stage, the patient is allowed to 
breathe the ambient air for two minutes, and is then seated in 
a semi-Fowler's position and given with comfortable nose 60 
clips. The patient is then provided with and breathes through 
mouthpiece 32 of the device of the present invention. Data 
processing unit 50 evaluates each breath against preset crite-
ria for suitability. For example, data processing unit 50 may 
be programmed to accept a minimum of 5 and a maximum of 65 
10 breaths that satisfy predetermined criteria for suitability, 
such as the requirement that each breath need have an accept-
A check 98 is then performed to see whether the carbox 
ratio has decreased past a predetermined threshold that sig-
nals the possibility of pulmonary embolism. For example, a 
threshold decrease in the carbox ratio of more than about 
twenty-five percent (25%) may represent an abnormal con-
dition that is consistent with possible pulmonary embolism 
100. No change or an increase in the carbox ratio suggests the 
that pulmonary embolism is unlikely 102. Similar logic can 
be used to compare other breathing parameters, including 
tidal volume, minute ventilation, airway deadspace, flow 
rates and various arithmetic manipulations of these variables 
to the baseline measurement to indicate other possible 
sources for the breathing difficulty. For example, measure-
ments of airway restriction as the possible cause of respira-
tory symptoms include measurement of flow-volume loops, 
FEVl, FVC, and the slope of the alveolar plateau observed on 
a real-time plot of the carbox ratio. 
As seen in FIGS. SA and B, statistical analysis 102 of the 
D-dimer test reveals that the test is very unpredictable when 
used postoperatively. In particular, the D-dimer suffers from 
very low diagnostic specificity in the post-surgical popula-
tion. By comparison, statistical analysis 104 ofintraoperative 
process 80 according to the present invention provides poten-
tial for higher diagnostic specificity. The mean coefficient of 
variability for the D-dimer when measured preoperatively 
then on schedule two to three days postoperatively is 65 
percent. The coefficient of variability of intraoperative pro-
cess 80, however, is only 16 percent. Thus, intraoperative 
process 80 is a more stable measurement in patients at high 
risk for pulmonary embolism who did not previously have 
pulmonary embolism. 
What is claimed is: 
1. A method of determining a likelihood of a pulmonary 
embolism in a patient, comprising the steps of: 
determining the carbox ratio of said patient prior to a sur-
gical procedure; 
determining the carbox ratio of said patient after to the 
surgical procedure; 
comparing said carbox ratio of said patient prior to the 
surgical procedure to said carbox ratio of said patient 
after the surgical procedure using a processing device; 
and 
determining the likelihood of a pulmonary embolism in 
said patient based on said comparing step. 
2. The method of claim 1, wherein the step of determining 
the carbox ratio of said patient prior to a surgical procedure 
comprises the step of measuring the instantaneous ratio of 
expired partial pressure of carbon dioxide divided by the 
partial pressure of oxygen (p02) at or near the end of a 
predetermined number of tidal volume breaths. 
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3. The method of claim 2, wherein the step of determining 
the carbox ratio of said patient after to a surgical procedure 
comprises the step of measuring the instantaneous ratio of 
expired partial pressure of carbon dioxide divided by the 
partial pressure of oxygen (p02) at or near the end of a 
predetermined number of tidal volume breaths. 
4. The method of claim 3, wherein a pulmonary embolism 
10 
14. The method of claim 13, wherein the step of measuring 
characteristics of the breath of the patient prior to the surgical 
procedure is performed after the patient breathes ambient air 
for at least two minutes. 
15. The method of claim 12, wherein the step of measuring 
characteristics of the breath of the patient prior to a surgical 
procedure is performed while the patient is wearing nose 
clips. is likely present in said patient when said carbox ratio of said 
patient after to the surgical procedure is twenty-five or more 
percent less than said carbox ratio of said patient prior to the 
surgical procedure. 
5. The method of claim 3, wherein a pulmonary embolism 
is likely not present in said patient when said carbox ratio of 
said patient after to the surgical procedure is equal to or more 
than said carbox ratio of said patient prior to the surgical 
procedure. 
16. The method of claim 13, wherein the step of measuring 
10 
characteristics of the breath of the patient after the surgical 
procedure is performed after the patient breathes ambient air 
for at least two minutes. 
17. A method of determining a likelihood of a pulmonary 
15 embolism in a surgical patient, comprising the steps of: 
6. The method of claim 3, wherein the step of determining 
the carbox ratio of said patient after to the surgical procedure 
is performed ifthe patient has difficulty breathing. 
7. The method of claim 1, wherein said carbox ratio of said 20 
patient prior to a surgical procedure and said carbox ratio of 
said patient after to a surgical procedure are stored in non-
volatile memory. 
8. A method of determining a likelihood of a pulmonary 
embolism in a patient, comprising the steps of: 
measuring characteristics of the breath of the patient prior 
to a surgical procedure; 
measuring characteristics of the breath of the patient after 
the surgical procedure; 
25 
comparing the characteristics of the breath of the patient 30 
prior to the surgical procedure with the characteristics of 
the breath of the patient after the surgical procedure 
using a processing device; and 
determining the likelihood of a pulmonary embolism in 
said patient based on said comparing step. 35 
9. The method of claim 8, wherein said characteristics of 
the breath of the patient comprise one or more characteristics 
selected from the group consisting of tidal volume, respira-
tory rate, minute ventilation, peak inspiratory flow, peak expi-
ratory flow, expired partial pressures of C02, and expired 40 
partial pressures of 02. 
(a) allowing the patient to breathe ambient air for at least 
two minutes prior to a surgical procedure; 
(b) seating the patient in the semi-Fowler's position prior to 
the surgical procedure; 
( c) placing nose clips on the patient prior to the surgical 
procedure; 
( d) measuring characteristics of the breath of the patient 
prior to the surgical procedure; 
( e) storing the characteristics of the breath of the patient in 
non-volatile memory prior to the surgical procedure; 
(f) repeating steps (a) through (d) after the surgical proce-
dure; 
(g) calculating the carbox ratio of the patient from the 
characteristics of the breath of the patient prior to the 
surgical procedure; 
(h) calculating the carbox ratio of the patient from the 
characteristics of the breath of the patient after the sur-
gical procedure; and 
(i) comparing characteristics of the breath of the patient 
prior to the surgical procedure with the characteristics of 
the breath of the patient prior to the surgical procedure 
using a processing device; and 
(j) determining the likelihood of a pulmonary embolism in 
said patient based on said comparing step. 
18. The method of claim 17, wherein the characteristics of 
the breath of the patient comprise one or more parameters 
selected from the group consisting of tidal volume, respira-
tory rate, minute ventilation, peak inspiratory flow, peak expi-
10. The method of claim 9, wherein the carbox ratio of the 
patient prior to the surgical procedure is calculated from 
characteristics of the breath of the patient prior to the surgical 
procedure. 
11. The method of claim 10, wherein the carbox ratio of the 
patient after the surgical procedure is calculated from char-
acteristics of the breath of the patient after to the surgical 
procedure. 
45 ratory flow, expired partial pressures of C02, and expired 
partial pressures of02. 
19. The method of claim 18, wherein a pulmonary embo-
lism is likely present in said patient when said carbox ratio of 
said patient after to the surgical procedure is twenty-five or 
more percent less than said carbox ratio of said patient prior to 
the surgical procedure. 
12. The method of claim 11, wherein the step of comparing 50 
the characteristics of the breath of the patient prior to the 
surgical procedure with the characteristics of the breath of the 
patient after the surgical procedure comprises comparing the 
carbox ratio of the patient prior to the surgical procedure to 
the carbox ratio of the patient after the surgical procedure. 
20. The method of claim 18, wherein a pulmonary embo-
lism is likely not present in said patient when said carbox ratio 
of said patient after to the surgical procedure is equal to or 
55 more than said carbox ratio of said patient prior to the surgical 
procedure. 13. The method of claim 12, wherein the step of measuring 
characteristics of the breath of the patient prior to the surgical 
procedure is performed while the patient is seated in the 
semi-Fowler's position. 
* * * * * 
